[1]
“COVID-19 AND PATIENTS UNDERGOING PHARMACOLOGICAL TREATMENTS FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES: PROTOCOL FOR A RAPID LIVING SYSTEMATIC REVIEW”, SciELO Preprints. 6º de maio de 2020. doi: 10.1590/SciELOPreprints.349.